000165
(EPM-000110),
v
ersion
09,
Apr
il
2017,
for
instr
uments
with
SW
20XX,
22XX
and
23XX
Circassia AB, an ISO 13485 certified company
Circassia AB, Hansellisgatan 13, SE-754 50 Uppsala, Sweden
Phone: +46 8 629 07 80, Fax: +46 8 629 07 81, E-mail: [email protected]
www.niox.com
NIOX MINO
®
is CE marked according to European In Vitro Diagnostic Device Directive 98/79/EC and is cleared 510(k) by FDA, k101034, (US).
Copyright
©
2017 Circassia AB, Uppsala, Sweden.
NIOX MINO
®
and NIOX
®
are registered trademarks of Circassia AB.
Patents:
Circassia’s NIOX products are protected by a number of patents in the US, Europe and a range
of other countries.
A N E W DI M EN SI O N I N AST H M A CAR E
Information in this document is subject to change.
Amendments will be made available by Circassia AB as they occur.
© Copyright 2017: Circassia AB, Uppsala, Sweden.
Based on the company’s intellectual property, Circassia develops and
commercializes product for the monitoring of nitric oxide (NO) as a marker
of inflammation, to improve the management and care of patients with
inflammatory disease in the airways.